EVOLUTION MPX Total Knee System
Suzhou Microport Orthorecon Co., Ltd. · Decision date Sep 10, 2026
What did the FDA decide?
The FDA recorded a substantially equivalent (SESE) decision for the EVOLUTION MPX™ Total Knee System, submitted by Suzhou Microport Orthorecon Co., Ltd., under 510(k) number K262293. The decision date is 09/10/2026; the application was received 07/07/2026. The device falls under regulation 888.3560, classification name Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer, with primary product code JWH and subsequent product code HRY. The review panel and medical specialty are both Orthopedic.
SESE denotes 510(k) clearance as substantially equivalent to a predicate device; it is not premarket approval. The record lists a Traditional submission, not reviewed by a third party, not a combination product, and without an authorized Predetermined Change Control Plan. The source does not include the predicate device, the specific components or changed items, or any summary of nonclinical or clinical data, so the technical basis for the equivalence finding remains unknown from this page.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Sep 10, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262293
- Regulatory pathway
- 510(k) premarket notification
- Product code
- JWH
- Decision code
- SESE
- Decision date
- Sep 10, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer.
- Product code
- JWH
- FDA device class
- 2
FDA decision timeline
K262293 received
Application receipt date recorded by FDA.
K262293 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code JWH
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
MicroPort Total Knee SystemK263065 | Suzhou Microport Orthorecon Co., Ltd. | 510(k) clearance | Oct 29, 2026 | FDA |
GMK ExtensionK262057 | Medacta International SA | 510(k) clearance | Sep 15, 2026 | FDA |
GSPE SpacerK260063 | The General Hospital Corporation, d/b/a Massachusetts | 510(k) clearance | Sep 11, 2026 | FDA |
| B-One Ortho, Corp. | 510(k) clearance | Sep 8, 2026 | FDA | |
ATTUNE Revision Knee SystemK262130 | Depuy Orthopaedics, Inc. | 510(k) clearance | Sep 4, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Suzhou Microport Orthorecon Co., Ltd.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Suzhou
Sources and methodology
- Original FDA record: K262293
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


